vs
Side-by-side financial comparison of Allstate (ALL) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $922.0M, roughly 1.4× Allstate). Allstate runs the higher net margin — 266.6% vs 7.3%, a 259.3% gap on every dollar of revenue. On growth, Allstate posted the faster year-over-year revenue change (7.2% vs 4.8%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ALL vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $1.3B |
| Net Profit | $2.5B | $97.3M |
| Gross Margin | — | 14.9% |
| Operating Margin | -1400.3% | 83.4% |
| Net Margin | 266.6% | 7.3% |
| Revenue YoY | 7.2% | 4.8% |
| Net Profit YoY | — | -42.0% |
| EPS (diluted) | $9.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | $1.3B | ||
| Q4 25 | $17.3B | $339.0M | ||
| Q3 25 | $17.3B | $327.3M | ||
| Q2 25 | $16.6B | $321.4M | ||
| Q1 25 | $16.5B | $330.6M | ||
| Q4 24 | $16.5B | $348.5M | ||
| Q3 24 | $16.6B | $345.5M | ||
| Q2 24 | $15.7B | $336.2M |
| Q1 26 | $2.5B | $97.3M | ||
| Q4 25 | $3.8B | $44.7M | ||
| Q3 25 | $3.7B | $38.7M | ||
| Q2 25 | $2.1B | $34.0M | ||
| Q1 25 | $595.0M | $58.0M | ||
| Q4 24 | $1.9B | $37.5M | ||
| Q3 24 | $1.2B | $33.8M | ||
| Q2 24 | $331.0M | $38.4M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | -1400.3% | 83.4% | ||
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 21.6% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 11.8% |
| Q1 26 | 266.6% | 7.3% | ||
| Q4 25 | 22.1% | 13.2% | ||
| Q3 25 | 21.7% | 11.8% | ||
| Q2 25 | 12.7% | 10.6% | ||
| Q1 25 | 3.6% | 17.5% | ||
| Q4 24 | 11.7% | 10.8% | ||
| Q3 24 | 7.2% | 9.8% | ||
| Q2 24 | 2.1% | 11.4% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $0.95 | ||
| Q3 25 | $13.95 | $0.81 | ||
| Q2 25 | $7.76 | $0.70 | ||
| Q1 25 | $2.11 | $1.17 | ||
| Q4 24 | $7.07 | $0.74 | ||
| Q3 24 | $4.33 | $0.66 | ||
| Q2 24 | $1.13 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $31.6B | $796.3M |
| Total Assets | $124.0B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $4.9B | $363.4M | ||
| Q3 25 | $8.7B | $296.4M | ||
| Q2 25 | $9.6B | $292.9M | ||
| Q1 25 | $6.5B | $306.8M | ||
| Q4 24 | $4.5B | $320.8M | ||
| Q3 24 | $7.0B | $299.3M | ||
| Q2 24 | $5.3B | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $7.5B | $1.2B | ||
| Q3 25 | $8.1B | $1.2B | ||
| Q2 25 | $8.1B | $1.2B | ||
| Q1 25 | $8.1B | $1.2B | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.1B | — |
| Q1 26 | $31.6B | $796.3M | ||
| Q4 25 | $30.6B | $911.5M | ||
| Q3 25 | $27.5B | $849.2M | ||
| Q2 25 | $24.0B | $882.3M | ||
| Q1 25 | $22.1B | $820.8M | ||
| Q4 24 | $21.4B | $906.9M | ||
| Q3 24 | $20.9B | $878.9M | ||
| Q2 24 | $18.6B | $905.4M |
| Q1 26 | $124.0B | $2.4B | ||
| Q4 25 | $119.8B | $2.5B | ||
| Q3 25 | $120.4B | $2.4B | ||
| Q2 25 | $115.9B | $2.5B | ||
| Q1 25 | $115.2B | $2.5B | ||
| Q4 24 | $111.6B | $2.5B | ||
| Q3 24 | $113.7B | $2.5B | ||
| Q2 24 | $108.4B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 0.24× | 1.34× | ||
| Q3 25 | 0.29× | 1.44× | ||
| Q2 25 | 0.34× | 1.39× | ||
| Q1 25 | 0.37× | 1.49× | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | — | $209.9M |
| FCF MarginFCF / Revenue | — | 15.7% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $3.0B | $93.6M | ||
| Q3 25 | $3.3B | $111.3M | ||
| Q2 25 | $1.9B | $17.4M | ||
| Q1 25 | $2.0B | $116.6M | ||
| Q4 24 | $1.7B | $43.8M | ||
| Q3 24 | $3.2B | $48.8M | ||
| Q2 24 | $2.4B | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $2.9B | $87.2M | ||
| Q3 25 | $3.2B | $106.3M | ||
| Q2 25 | $1.9B | $13.6M | ||
| Q1 25 | $1.9B | $100.9M | ||
| Q4 24 | $1.7B | $35.2M | ||
| Q3 24 | $3.1B | $39.4M | ||
| Q2 24 | $2.3B | $-33.1M |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 16.7% | 25.7% | ||
| Q3 25 | 18.8% | 32.5% | ||
| Q2 25 | 11.3% | 4.2% | ||
| Q1 25 | 11.4% | 30.5% | ||
| Q4 24 | 10.0% | 10.1% | ||
| Q3 24 | 18.9% | 11.4% | ||
| Q2 24 | 14.7% | -9.8% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 0.5% | 1.9% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.6% | 4.7% | ||
| Q4 24 | 0.3% | 2.5% | ||
| Q3 24 | 0.4% | 2.7% | ||
| Q2 24 | 0.4% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 0.78× | 2.09× | ||
| Q3 25 | 0.88× | 2.88× | ||
| Q2 25 | 0.89× | 0.51× | ||
| Q1 25 | 3.30× | 2.01× | ||
| Q4 24 | 0.88× | 1.17× | ||
| Q3 24 | 2.69× | 1.44× | ||
| Q2 24 | 7.13× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
